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Many enveloped viruses depend on the membrane remodeling machinery of their host cells to
complete their life cycle. In this issue, Rossman et al. (2010) now demonstrate that influenza virus
possesses its own device for releasing nascent virus particles from the plasma membrane, the M2
proton-selective ion channel, which can substitute for the host cell’s ESCRT pathway.Many viruses are severely constrained by
their small genomes, and thus, viruses
have evolvedmultiple strategies to coerce
their host cells to help complete their life
cycle. One of the most well studied exam-
ples of this strategy is viruses hijacking
the eukaryotic ESCRT (endosomal sorting
complex required for transport) pathway.
Enveloped viruses, such as HIV, Ebola
virus, and Rabies virus, have a lipid bilayer
or vesicle surrounding their capsid. The
ESCRT pathway generates similar types
of vesicles while sorting proteins among
the plasma membrane, endosomes, and
lysosomes (Hurley and Hanson, 2010).
Therefore, it intuitively makes sense that
many enveloped viruses engage the
ESCRT pathway to facilitate budding
from the plasma membrane.
However, dependence on the ESCRT
pathway is not universal. In particular,
the release of influenza virus from infected
cells does not require a functional ESCRT
system (Chen and Lamb, 2008), raising
the possibility that influenza virus exploits
a new cellular pathway to escape from
cells. Now, in this issue of Cell, Rossman
et al. (2010) report an alternative explana-
tion; they find that the influenza virus
surprisingly relies on its own protein, the
M2 proton-selective ion channel, to
cleave viral particles from the plasma
membrane.
The assembly and release of enveloped
viruses from an infected cell involves two
major steps. First, a portion of the plasma
membrane curves up into a ‘‘bud’’ projec-
ting away from the cytosol (Figure 1). Then
the ‘‘neck’’ of the bud ‘‘pinches off’’
to disconnect the vesicle from themembrane, a process known as mem-
brane scission.
The initial hints that this second step
requires assistance from the host cell
came when researchers identified the
L domains of retroviruses (Bieniasz,
2006). These short peptides are required
to release assembled virus particles from
the cell, and they are known to ultimately
engage the ESCRT-III complex, the
component of the ESCRT pathway that
mediates cleavage of membrane necks
during endosomal budding and cytoki-
nesis (Carlton and Martin-Serrano, 2007;
Saksena et al., 2007). L domains were
later identified in numerous enveloped
viruses, and a considerable number of
these are now known to require the
ESCRT pathway for budding (Chen and
Lamb, 2008). Although the influenza virus
lacks a conventional L domain, the matrix
protein (M1) of influenza binds to a subunit
of the ESCRT-I complex, suggesting that
this virus may still rely on the ESCRT
pathway for budding (Bruce et al., 2009).
However, neither M1 nor a functioning
ESCRT system is strictly required for the
budding of influenza (Bruce et al., 2009;
Chen and Lamb, 2008). Thus, the details
of how nascent influenza virus particles
disconnect from the plasma membrane
have been a mystery.
Interestingly, transmembrane proteins,
such as hemagglutinin (HA) and neur-
aminidase (NA) (Figure 1), drive the forma-
tion of influenza buds instead of internal
proteins, as is the case for other viruses
(Chen and Lamb, 2008). One of these
transmembrane proteins, the M2 proton-
selective ion channel, has attractedCell 142, Seconsiderable attention because it is the
target of the antiviral drug amantadine.
When influenza enters a cell by endocy-
tosis, M2 triggers uncoating of the virus
by acidifying the interior of the virus
particle. Thus, amantadine inhibits an
early stage of the viral life cycle by block-
ing M2’s channel (Pinto and Lamb, 2006).
Recent studies suggest that M2 also
plays a critical but less appreciated role
later during viral assembly or budding.
This second function depends on specific
regions in the channel’s cytoplasmic tail
(Chen et al., 2008), but the exact role
that M2 plays in viral morphogenesis has
been difficult to pinpoint.
The study by Rossman and colleagues
now reveals that purified influenza M2
can alter the curvature of lipid bilayers
in vitro. Moreover, in these liposome
assays, M2 possesses similar capabilities
as the activated ESCRT-III protein
complex (Hurley and Hanson, 2010).
Like ESCRT-III, M2 induces the inward
budding and detachment of small vesi-
cles inside larger vesicles (i.e., giant unila-
mellar vesicles), an artificial system that
mimics virus budding from the plasma
membrane. Furthermore, the authors
found that an amphipathic helix in M2’s
cytoplasmic tail is both required and
sufficient for the detachment of vesicle
buds in this in vitro model system. Impor-
tantly, mutating the hydrophobic face of
this helix significantly reduces viral
release in vivo, indicating that this 17
amino acid helix is crucial for the release
of influenza virus in vivo. Together, these
results suggest that M2 serves as
a substitute for ESCRT complexes duringptember 17, 2010 ª2010 Elsevier Inc. 839
Figure 1. Model of Influenza Virus Budding
The formation of spherical or tubular buds at the plasma membrane is driven by the viral transmembrane proteins hemagglutinin (HA) and neuraminidase (NA).
Thematrix proteinM1 is brought into the virus particle by contactswith HA andNA. In turn, M1 recruits into the emerging bud the viral ribonucleoprotein structures
(blue bars) and small quantities of the transmembrane protein M2 (which is a homotetramer but is depicted as a monomer for simplicity). Because HA and NA
concentrate in raft-like lipid microdomains, the membrane covering the emerging bud (green) has a higher cholesterol content than the bulk plasma membrane
(red). This phase separation results in a line tension that tends to promote bud neck constriction to minimize the strain at the phase boundary. M2 accumulates at
the phase boundary, and its amphipathic helix (yellow square) promotes membrane fission by modulating this line tension (Rossman et al., 2010).influenza virus budding. Furthermore,
these results raise the possibility that
other enveloped viruses that appear to
be independent of the ESCRT system
may also encode functional equivalents
to M2.
It seems remarkable that a small
portion of a single viral protein can replace
the function of a cellular machine as
complex as the ESCRT pathway, which
includes more than 20 proteins in
humans. During ESCRT-mediated sorting
of cargo into vesicles that bud into endo-
somes, the upstream components of the
pathway, the ESCRT-I and the ESCRT–II
complexes, initially form the vesicle
buds. The downstream component,
ESCRT-III, can also induce buds, but at
physiological concentrations it merely
mediates membrane scission (Hurley840 Cell 142, September 17, 2010 ª2010 Elsand Hanson, 2010). Rossman and
colleagues find that influenza virus lacking
M2 can form buds, but the buds fail to
detach and instead exhibit a ‘‘beads-on-
a-string’’ morphology at the plasma
membrane. Thus, despite the capacity of
the M2 protein to produce buds in vitro,
this transmembrane protein probably
functions primarily as a membrane scis-
sion factor in vivo, similar to ESCRT-III.
The results presented by Rossman and
colleagues raise many new questions
about the assembly and budding of
influenza virus. One important future
goal will be to determine how the amphi-
pathic helix of M2 bends membranes
and carries out scission. Some cellular
trafficking proteins also possess amphi-
pathic helices that induce curvature into
membranes. However, these proteinsevier Inc.usually insert like wedges into the cyto-
solic leaflet of the plasma membrane,
bending the membrane toward the
cytosol (McMahon and Gallop, 2005). In
contrast, M2 curves the membrane away
from the cytosol, and thus, it is not clear
how its amphipathic helix can induce
budding in this opposite direction.
Another surprising result from the study
by Rossman and colleagues is that M2
facilitates budding only from membranes
containing relatively low concentrations
of cholesterol. At first, this seems coun-
terintuitive because influenza virus is
believed to bud from cholesterol-rich
domains of the plasma membrane (Fig-
ure 1). The authors speculate that this
restriction in M2 activity delays mem-
brane scission until the virus particle is
fully assembled. In this intriguing model,
the amphipathic helix of M2 would first
contact a cholesterol-rich environment;
then as the virus completes assembly,
M2 would eventually contact surrounding
membrane regions with less cholesterol.
At this point, M2 could promote scission
by modifying the line tension between
the bud and the bulk plasma mem-
brane (Figure 1). This mechanism, how-
ever, relies on forces generated at the
boundary of two lipid domains. This is
perhaps not the complete story because
M2 can drive vesicle budding and
detachment even from simple model
membranes that lack lipids commonly
involved in establishing such membrane
domains.Clearly, the study by Rossman and
colleagues marks only the beginning of
a fascinating story that will shed new light
on a fundamental but still poorly under-
stood stage in the life cycle of enveloped
viruses. In addition, their study identifies
yet another essential function of the M2
channel. It will be interesting to see if
M2’s role in budding can be exploited as
a drug target to treat influenza.REFERENCES
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Cells possess internal 24 hr or circadian clocks that synchronize physiological processes with
daily cycles of light and nutrient availability. In this issue, Asher et al. (2010) find that PARP-1
(poly(ADP-ribose) polymerase 1) modifies components of the clock machinery in response to
feeding, providing a mechanism for how metabolic rhythms coordinate with circadian rhythms.Many organisms synchronize their
behavior, physiology, and metabolism
with the 24 hr rotation of the Earth. In
mammals, a master pacemaker is located
in the hypothalamic region called the
suprachiasmatic nucleus (SCN), which
contains a cluster of 10,000 neurons.
Each SCN neuron expresses a transcrip-
tional feedback loop that self-generates
an oscillation with a period of 24 hr
(Green et al., 2008). Cells in peripheral
tissues, such as the liver, contain similar
cell-autonomous clocks, and the SCN
synchronizes the oscillation of their
internal clocks to coordinate rhythms
throughout the body. However, in both
the SCN and peripheral tissues, the
molecular clocks must integrate extracel-
lular cues to maintain synchrony with theenvironment. Light is the dominant cue
for the central clock in the SCN, but for
peripheral tissues, metabolic cycles,
such as feeding and fasting, can also
regulate the internal clocks.
The link between circadian and meta-
bolic rhythms is an area of intense study
because disrupting the synchrony is
thought to contribute to the etiology of
disorders such as diabetes, obesity, and
cardiovascular disease (Green et al.,
2008). Nonetheless, how circadian and
metabolic systems interact remains
largely undefined; in particular, how feed-
ing directly modulates the molecular
oscillators in peripheral tissues has been
a mystery. In this issue of Cell, Asher
et al. (2010) find that the activity of poly
(ADP-ribose) polymerase 1 (PARP-1) inthe liver of mice oscillates in synchrony
with the feeding-fasting cycle, providing
a new link betweenmetabolism and circa-
dian rhythms.
PARP-1 is a highly conserved nuclear
protein that adds chains of ADP-ribose
molecules to proteins in a process called
ADP-ribosylation (or poly ADP-ribosyla-
tion). PARP-1 uses nicotinamide adenine
dinucleotide (NAD+) to synthesize these
polymers, which can include up to
200 ADP-ribose units. Like other post-
translational modifications, ADP-ribosyla-
tion alters protein function; chains of
ADP-ribose are negatively charged,
and thus their addition is believed to
disrupt electrostatic interactions, such
as those involved in DNA binding. The
major substrate of PARP-1 is itself, andptember 17, 2010 ª2010 Elsevier Inc. 841
